The Procter & Gamble Company (NYSE:PG) Shares Sold by F M Investments LLC

F M Investments LLC trimmed its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 4.8% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 61,678 shares of the company’s stock after selling 3,082 shares during the quarter. F M Investments LLC’s holdings in Procter & Gamble were worth $10,668,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Itau Unibanco Holding S.A. bought a new stake in Procter & Gamble during the 2nd quarter valued at $28,000. Fairway Wealth LLC bought a new position in Procter & Gamble in the 2nd quarter valued at about $29,000. Ruedi Wealth Management Inc. lifted its stake in shares of Procter & Gamble by 64.7% in the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after acquiring an additional 77 shares during the period. POM Investment Strategies LLC acquired a new position in shares of Procter & Gamble during the 2nd quarter valued at $34,000. Finally, Quest Partners LLC acquired a new position in Procter & Gamble during the second quarter worth about $36,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Transactions at Procter & Gamble

In related news, insider Susan Street Whaley sold 450 shares of Procter & Gamble stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total transaction of $76,149.00. Following the sale, the insider now directly owns 13,072 shares of the company’s stock, valued at $2,212,043.84. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Procter & Gamble news, insider Susan Street Whaley sold 450 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total transaction of $76,149.00. Following the sale, the insider now directly owns 13,072 shares of the company’s stock, valued at approximately $2,212,043.84. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Andre Schulten sold 13,041 shares of the firm’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the transaction, the chief financial officer now owns 37,208 shares of the company’s stock, valued at $6,325,360. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 389,144 shares of company stock worth $66,184,385. Insiders own 0.18% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Jefferies Financial Group lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating and reduced their price objective for the company from $182.00 to $175.00 in a research report on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft increased their price objective on Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Morgan Stanley boosted their target price on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research report on Monday, October 21st. StockNews.com lowered Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, Barclays downgraded Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price objective on the stock. in a report on Monday, September 30th. Nine analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $177.00.

Get Our Latest Stock Report on PG

Procter & Gamble Stock Performance

Shares of PG stock traded down $0.08 during trading on Friday, reaching $165.10. The company had a trading volume of 5,455,095 shares, compared to its average volume of 6,645,703. The Procter & Gamble Company has a one year low of $142.50 and a one year high of $177.94. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.75 and a quick ratio of 0.55. The firm’s 50 day simple moving average is $171.62 and its two-hundred day simple moving average is $167.91. The company has a market capitalization of $388.82 billion, a PE ratio of 28.47, a PEG ratio of 3.59 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last posted its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same period last year, the business posted $1.83 EPS. Procter & Gamble’s revenue was down .6% compared to the same quarter last year. Sell-side analysts forecast that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.44%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s dividend payout ratio is currently 69.48%.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.